Reference : Cost-effectiveness of denosumab compared with generic alendronate in the treatment of...
Scientific congresses and symposiums : Paper published in a journal
Human health sciences : Endocrinology, metabolism & nutrition
Business & economic sciences : Special economic topics (health, labor, transportation…)
http://hdl.handle.net/2268/70150
Cost-effectiveness of denosumab compared with generic alendronate in the treatment of postmenopausal osteoporotic women
English
Hiligsmann, Mickaël mailto [Université de Liège - ULg > HEC-Ecole de gestion de l'ULg > > >]
Reginster, Jean-Yves mailto [Université de Liège - ULg > Département des sciences de la santé publique > Santé publique, Epidémiologie et Economie de la santé >]
Nov-2010
Value in Health
Blackwell Publishing
13
7
A309
Yes (verified by ORBi)
No
International
1098-3015
1524-4733
Oxford
United Kingdom
ISPOR 13th Annual European Congress
du 6 novembre 2010 au 9 novembre 2009
ISPOR
Prague
République Tchèque
Unité de Recherches en Pharmaco-Economie (ECOHEALTH)
Researchers ; Professionals
http://hdl.handle.net/2268/70150

File(s) associated to this reference

Fulltext file(s):

FileCommentaryVersionSizeAccess
Restricted access
Abstract_ISPOR2010.pdfAuthor postprint14.84 kBRequest copy

Additional material(s):

File Commentary Size Access
Restricted access
ISPOR_2010_Dmab.pdfPrésentation Poster618.71 kBRequest copy

Bookmark and Share SFX Query

All documents in ORBi are protected by a user license.